Company intelligence / Profile preview

VaxThera

Rionegro, Antioquia, Colombia

Ownership: Private
Employees: ~150
Development stage: Other

Overview

VaxThera reports a universal SARS-CoV-2 vaccine in preclinical studies (originally in Wisconsin) and has obtained at least one patent for a vaccine designed to protect against multiple Covid-19 variants and Mpox; as of 2024–2025, its new 35,000 m² facility near Medellín/Rionegro is being brought through INVIMA certification for commercial-scale manufacturing, but no VaxThera-originated products are yet reported as in human clinical trials.[1][5][7]

Therapeutic areas: Infectious Diseases
Modalities: VaccinemRNA-based drugsViral vectorBiologic
Industry: Biotech

Drug pipeline

10 assets

VaxThera Chikungunya vaccine

Approved

9 more assets in the full pipeline.

Request access →

Partnerships

Ministry of Health of Colombia[5]National Institute of Health of Colombia (Instituto Nacional de Salud)[5]European Investment Bank (project financing partner)[6]Forward Bio Labs (R&D collaboration site in Madison, Wisconsin)[3]Academic and industrial partners in Brazil and Argentina for vaccine research networks[5]

Beyond the preview

Go deeper on VaxThera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VaxThera.

Explore the full profile